Metagenomi Reports Improved Gene Editing Efficiency with Compact CRISPR Nuclease

Metagenomi Therapeutics has announced research detailing their compact CRISPR nuclease, MG119-28, which demonstrates enhanced gene editing efficiency. The improved performance is attributed to the tool's superior structural stability and more stable guide RNA. This publication marks a significant advancement in the field of genome editing technology.